Back
First published:
Last published:
An independent evaluation of ASHM’s HBV s100 Prescriber Program was conducted in 2018, covering the period 1 Jul 2015 – 31 December 2017. The evaluation was mixed-methods, comprising interviews with GP prescribers, specialists, government representatives, program partners and consumers (n=30), a survey of GP prescribers (n=135), as well as a review of program data and analysis of population-level data. A summary of the results of the evaluation is presented here.
This is not an extensive list of professions, and other practitioners might benefit from this resource
ASHM Head Office - Sydney
Level 3, 160 Clarence Street Sydney, NSW 2000
Tel: (+61) 02 8204 0700
ASHM acknowledges the Traditional Owners of Country across the various lands on which we live and work. We recognise Aboriginal and Torres Strait Islander peoples’ continuing connection to land, water, and community and we pay our respects to Elders past and present. ASHM acknowledges Sovereignty in this country has never been ceded. It always was, and always will be, Aboriginal land.
The information provided on this website and its related websites and guidelines, and the resources made available by ASHM in any format or medium, are for general information purposes only and are not intended as medical advice or as a substitute for consultation with a qualified healthcare professional. While ASHM Health strives to provide accurate and current resources and information, the resources, information and guidelines made available by ASHM Health do not provide personalised medical advice, diagnosis, or treatment. Healthcare professionals should apply their clinical judgment and consider individual circumstances when using this information. To the extent permitted by law, ASHM Health disclaims all liability for any outcomes resulting from reliance on the information provided. For specific medical concerns, please consult a licensed healthcare provider.
ASHM Health | ABN 48 264 545 457 | CFN 17788 | Copyright © 2024 ASHM
